119 related articles for article (PubMed ID: 23564472)
1. Potential mechanism of the anti-trypanosomal activity of organoruthenium complexes with bioactive thiosemicarbazones.
Demoro B; Rossi M; Caruso F; Liebowitz D; Olea-Azar C; Kemmerling U; Maya JD; Guiset H; Moreno V; Pizzo C; Mahler G; Otero L; Gambino D
Biol Trace Elem Res; 2013 Jun; 153(1-3):371-81. PubMed ID: 23564472
[TBL] [Abstract][Full Text] [Related]
2. Platinum-based complexes of bioactive 3-(5-nitrofuryl)acroleine thiosemicarbazones showing anti-Trypanosoma cruzi activity.
Vieites M; Otero L; Santos D; Olea-Azar C; Norambuena E; Aguirre G; Cerecetto H; González M; Kemmerling U; Morello A; Diego Maya J; Gambino D
J Inorg Biochem; 2009 Mar; 103(3):411-8. PubMed ID: 19187969
[TBL] [Abstract][Full Text] [Related]
3. Activity on Trypanosoma cruzi, erythrocytes lysis and biologically relevant physicochemical properties of Pd(II) and Pt(II) complexes of thiosemicarbazones derived from 1-indanones.
Santos D; Parajón-Costa B; Rossi M; Caruso F; Benítez D; Varela J; Cerecetto H; González M; Gómez N; Caputto ME; Moglioni AG; Moltrasio GY; Finkielsztein LM; Gambino D
J Inorg Biochem; 2012 Dec; 117():270-6. PubMed ID: 23063173
[TBL] [Abstract][Full Text] [Related]
4. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents.
Vieites M; Otero L; Santos D; Toloza J; Figueroa R; Norambuena E; Olea-Azar C; Aguirre G; Cerecetto H; González M; Morello A; Maya JD; Garat B; Gambino D
J Inorg Biochem; 2008; 102(5-6):1033-43. PubMed ID: 18226837
[TBL] [Abstract][Full Text] [Related]
5. New organoruthenium complexes with bioactive thiosemicarbazones as co-ligands: potential anti-trypanosomal agents.
Demoro B; Sarniguet C; Sánchez-Delgado R; Rossi M; Liebowitz D; Caruso F; Olea-Azar C; Moreno V; Medeiros A; Comini MA; Otero L; Gambino D
Dalton Trans; 2012 Feb; 41(5):1534-43. PubMed ID: 22138896
[TBL] [Abstract][Full Text] [Related]
6. Novel antitrypanosomal agents based on palladium nitrofurylthiosemicarbazone complexes: DNA and redox metabolism as potential therapeutic targets.
Otero L; Vieites M; Boiani L; Denicola A; Rigol C; Opazo L; Olea-Azar C; Maya JD; Morello A; Krauth-Siegel RL; Piro OE; Castellano E; González M; Gambino D; Cerecetto H
J Med Chem; 2006 Jun; 49(11):3322-31. PubMed ID: 16722651
[TBL] [Abstract][Full Text] [Related]
7. Rhenium(I) tricarbonyl compounds of bioactive thiosemicarbazones: Synthesis, characterization and activity against Trypanosoma cruzi.
Rodríguez Arce E; Machado I; Rodríguez B; Lapier M; Zúñiga MC; Maya JD; Olea Azar C; Otero L; Gambino D
J Inorg Biochem; 2017 May; 170():125-133. PubMed ID: 28237731
[TBL] [Abstract][Full Text] [Related]
8. Novel ruthenium(II) cyclopentadienyl thiosemicarbazone compounds with antiproliferative activity on pathogenic trypanosomatid parasites.
Fernández M; Arce ER; Sarniguet C; Morais TS; Tomaz AI; Azar CO; Figueroa R; Diego Maya J; Medeiros A; Comini M; Helena Garcia M; Otero L; Gambino D
J Inorg Biochem; 2015 Dec; 153():306-314. PubMed ID: 26275470
[TBL] [Abstract][Full Text] [Related]
9. Water-soluble ruthenium complexes bearing activity against protozoan parasites.
Sarniguet C; Toloza J; Cipriani M; Lapier M; Vieites M; Toledano-Magaña Y; García-Ramos JC; Ruiz-Azuara L; Moreno V; Maya JD; Azar CO; Gambino D; Otero L
Biol Trace Elem Res; 2014 Jun; 159(1-3):379-92. PubMed ID: 24740394
[TBL] [Abstract][Full Text] [Related]
10. Effect of ruthenium complexation on trypanocidal activity of 5-nitrofuryl containing thiosemicarbazones.
Pagano M; Demoro B; Toloza J; Boiani L; González M; Cerecetto H; Olea-Azar C; Norambuena E; Gambino D; Otero L
Eur J Med Chem; 2009 Dec; 44(12):4937-43. PubMed ID: 19783078
[TBL] [Abstract][Full Text] [Related]
11. Screening organometallic binuclear thiosemicarbazone ruthenium complexes as potential anti-tumour agents: cytotoxic activity and human serum albumin binding mechanism.
Demoro B; de Almeida RF; Marques F; Matos CP; Otero L; Costa Pessoa J; Santos I; Rodríguez A; Moreno V; Lorenzo J; Gambino D; Tomaz AI
Dalton Trans; 2013 May; 42(19):7131-46. PubMed ID: 23519281
[TBL] [Abstract][Full Text] [Related]
12. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of New Thiosemicarbazones and Semicarbazones Containing the 1,2,3-1H-triazole-isatin Scaffold: Trypanocidal, Cytotoxicity, Electrochemical Assays, and Molecular Docking.
Silva BNM; Sales Junior PA; Romanha AJ; Murta SMF; Lima CHS; Albuquerque MG; D'Elia E; Rodrigues JGA; Ferreira VF; Silva FC; Pinto AC; Silva BV
Med Chem; 2019; 15(3):240-256. PubMed ID: 30332972
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity and mechanism of action against the protozoan parasite Trypanosoma cruzi of 5-nitrofuryl containing thiosemicarbazones.
Aguirre G; Boiani L; Cerecetto H; Fernández M; González M; Denicola A; Otero L; Gambino D; Rigol C; Olea-Azar C; Faundez M
Bioorg Med Chem; 2004 Sep; 12(18):4885-93. PubMed ID: 15336268
[TBL] [Abstract][Full Text] [Related]
15. Insight into the bioreductive mode of action of antitrypanosomal 5-nitrofuryl containing thiosemicarbazones.
Otero L; Maya JD; Morello A; Rigol C; Barriga G; Rodríguez J; Folch C; Norambuena E; González M; Azar CO; Cerecetto H; Gambino D
Med Chem; 2008 Jan; 4(1):11-7. PubMed ID: 18220967
[TBL] [Abstract][Full Text] [Related]
16. Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships.
Donnici CL; Araújo MH; Oliveira HS; Moreira DR; Pereira VR; de Assis Souza M; de Castro MC; Leite AC
Bioorg Med Chem; 2009 Jul; 17(14):5038-43. PubMed ID: 19539479
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and structure-activity relationships of parasiticidal thiosemicarbazone cysteine protease inhibitors against Plasmodium falciparum, Trypanosoma brucei, and Trypanosoma cruzi.
Greenbaum DC; Mackey Z; Hansell E; Doyle P; Gut J; Caffrey CR; Lehrman J; Rosenthal PJ; McKerrow JH; Chibale K
J Med Chem; 2004 Jun; 47(12):3212-9. PubMed ID: 15163200
[TBL] [Abstract][Full Text] [Related]
18. Gold(III) complexes with ONS-Tridentate thiosemicarbazones: Toward selective trypanocidal drugs.
Rettondin AR; Carneiro ZA; Gonçalves AC; Ferreira VF; Oliveira CG; Lima AN; Oliveira RJ; de Albuquerque S; Deflon VM; Maia PI
Eur J Med Chem; 2016 Sep; 120():217-26. PubMed ID: 27191616
[TBL] [Abstract][Full Text] [Related]
19. Thiosemicarbazones derived from 1-indanones as new anti-Trypanosoma cruzi agents.
Caputto ME; Fabian LE; Benítez D; Merlino A; Ríos N; Cerecetto H; Moltrasio GY; Moglioni AG; González M; Finkielsztein LM
Bioorg Med Chem; 2011 Nov; 19(22):6818-26. PubMed ID: 22000947
[TBL] [Abstract][Full Text] [Related]
20. New heterobimetallic ferrocenyl derivatives are promising antitrypanosomal agents.
Rodríguez Arce E; Putzu E; Lapier M; Maya JD; Olea Azar C; Echeverría GA; Piro OE; Medeiros A; Sardi F; Comini M; Risi G; Salinas G; Correia I; Pessoa JC; Otero L; Gambino D
Dalton Trans; 2019 Jun; 48(22):7644-7658. PubMed ID: 31049548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
